中新健康丨小心！这个肺部“隐形杀手”经常被误判为感冒

Core Viewpoint - Interstitial lung disease (ILD) is often misdiagnosed as common respiratory infections like colds or pneumonia, leading to delayed treatment and irreversible lung damage [1][2]. Group 1: Understanding Interstitial Lung Disease - ILD involves changes in the lung's structural components, particularly the interstitial tissue, often due to immune system abnormalities [2]. - Early symptoms of ILD, such as dry cough and shortness of breath, are frequently mistaken for common colds, resulting in misdiagnosis [2][3]. - High-resolution CT scans are essential for diagnosing ILD, distinguishing between inflammatory and fibrotic types [2]. Group 2: Risk Factors and Patient Demographics - ILD is more prevalent among the elderly, particularly those with connective tissue diseases like rheumatoid arthritis and systemic lupus erythematosus [3]. - Patients with systemic symptoms, including joint pain and specific skin rashes, should be evaluated for ILD [3]. Group 3: Treatment and Management - Treatment for ILD requires a dual approach, addressing both the underlying connective tissue disease and the lung condition itself [3]. - Immunotherapy can help control the primary disease and slow ILD progression, while antifibrotic medications are necessary for patients with existing fibrosis [3]. - Without proper treatment, approximately 50% of patients may experience a decline in five-year survival rates [3]. Group 4: Importance of Early Detection - Specialized clinics for ILD have been established to enhance patient management through early identification and intervention [4]. - Patients with abnormal CT findings, such as ground-glass opacities or fibrosis, should seek immediate evaluation from respiratory specialists [4]. - Regular follow-ups are crucial for diagnosed patients, with initial monthly visits transitioning to quarterly as the condition stabilizes [4].